Filter by
Search
Showing 145 results for "eric"
- ADF attorneys available to media after oral arguments
- In new brief, ADF attorneys provide detail on why US Supreme Court should require the FDA to restore safety standards for abortion drugs
- Court rejects majority of GenBioPro’s challenge to state’s pro-life laws, allows suit to continue regarding prohibition on chemical abortion by telehealth
- West Virginia attorney general, ADF attorneys ask 4th Circuit to uphold state pro-life laws
- ADF filed brief on behalf of 8,899 ministers, churches
- ADF and ADF-allied attorneys prevail in arguing that conscience rights for pharmacists should be respected while state’s appeal proceeds
- Appeals court ends mail-order abortion regime, requires FDA to protect health, safety of women
- ADF attorneys file suit against Indiana Bureau of Motor Vehicles for banning personalized plates that mention God while issuing its own
- The following quote may be attributed to Alliance Defending Freedom Senior Legal Counsel Erik Stanley regarding the Texas Supreme Court’s decision Friday that requires the city of Houston to either repeal or put to a vote a city ordinance that qualified for the ballot but that city officials illegally kept off. Those officials, including Mayor Anise Parker, also unsuccessfully attempted to subpoena the sermons and communications of pastors, known as the “Houston 5,” whom ADF represented in Woodfill v. Parker: “Public officials should not be allowed to run roughshod over the right of the people ...
- The following quote may be attributed to Alliance Defending Freedom Senior Counsel Erin Hawley regarding an administrative stay the U.S. Supreme Court issued Friday in Alliance for Hippocratic Medicine v. U.S. Food and Drug Administration: “The entry of a brief administrative stay is standard operating procedure whenever the Supreme Court is asked to consider an emergency request like this one. It gives the court sufficient time to consider the parties’ arguments before ruling. We look forward to explaining why the FDA has not met its heavy burden to pause the parts of the district court’s ...